Overview

Tamsulosin for Thyroid Lid Retraction

Status:
Recruiting

Trial end date:
2021-12-01

Target enrollment:
0

Participant gender:
All

Summary

The purpose of this study is to examine the effect of using Tamsulosin for treatment of eyelid retraction as part of thyroid eye disease. The treatment will be offered to all thyroid patients suffering from eyelid retraction who are treated at the thyroid clinic in Sheba's Ophthalmology department. All patient will receive information about the drug Tamsulosin, the possible side effects, and the alternative treatment options for retraction. Patients recruited will take 0.4mg/day Tamsulosin for 3 months and will have follow-ups at 1 week, 1 month and 3 months to evaluate the retraction status.

Phase:

N/A

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Sheba Medical Center

Treatments:

Tamsulosin

Criteria

Inclusion Criteria:

- Thyroid eye disease patients suffering from upper eyelid retraction in one or both
eyes

Exclusion Criteria:

- pregnant/breastfeeding women

- previous eyelid surgery/trauma